Yun He

This inventor holds 48 USPTO granted patents and 19 published patent applications and 9 EPO patents, primarily in Antibody Therapeutics. Top assignees: Irm LLC, Abbott Laboratories Corporation, Hoffmann-La Roche Inc.. Active years: 1995-2026.

USPTO Granted Patents = 48 (Patent Applications = 19)

% Patents Active = 39.6

EPO Patents = 9 (Patent Applications = 31)

Average Co-Inventor Count = 6.8

ph-index = 12

Forward Citations = 401(Granted Patents)

Location History:

Milwaukee, WI (US) (1995)
Zion, IL (US) (1996 - 2000)
Carlsbad, CA (US) (2003 - 2009)
San Diego, CA (US) (1997 - 2012)
Shanghai, CN (2009 - 2021)

Company Filing History:

Abbott Laboratories Corporation

patents

10 out of 5,011

Hoffmann-La Roche Inc.

patents

4. 6 out of 1,203

Scripps Research Institute

Harbour Biomed (Shanghai) Co., Ltd

patents

7. 2 out of 3

Harbour Biomed (Shanghai) Co., Ltd.

patents

8. 1 out of 138

East China University of Science and Technology

patents

9. 1 out of 1,035

Isis Pharmaceuticals, Inc.

patents

Years Active: 1995-2026

Loading Chart...

Areas of Expertise:

CD73 Antibody

CTLA-4 Antibody

Bone Morphogenetic Protein

Polyethylene Catalyst

Protein Kinase Inhibitors

TPO Mimetics

Immunosuppressants

Anti-HIV Compounds

Bicyclic Compounds

Oxindoles

Epothilone Derivatives

Chemical Synaptic Transmission

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662537 - ANTI-PD-L1 ANTIGEN BINDING PROTEIN AND APPLICATION THEREOF (2026-06-23),

2. 12617862 - ANTI-CD73 ANTIBODY AND APPLICATION THEREOF (2026-05-05),

3. 12240905 - Antibodies binding CTLA-4 and uses thereof (2025-03-04),

4. 11098122 - Antibodies binding CTLA-4 and uses thereof (2021-08-24),

5. 10047155 - Antibodies targeting bone morphogenetic protein 9 (BMP9) and methods therefor (2018-08-14),

6. 9725530 - Supported metal oxide double active center polyethylene catalyst, process for preparing the same and use thereof (2017-08-08),

7. 8642629 - Naphthylacetic acids (2014-02-04),

8. 8592594 - Tetrahydro-quinoline derivatives (2013-11-26),

9. 8420675 - Aminotetrahydroindazoloacetic acids (2013-04-16),

10. 8354443 - Cyclopropane indolinone derivatives (2013-01-15),

11. 8268870 - Aminotetrahydroindazoloacetic acids (2012-09-18),

12. 8163781 - Bi-aryl aminotetralines (2012-04-24),

13. 8158634 - Compounds and compositions as inhibitors of cannabinoid receptor 1 activity (2012-04-17),

14. 8153671 - Heterotetracyclic compounds as TPO mimetics (2012-04-10),

15. 8138208 - Aminotetrahydroindazoloacetic acids (2012-03-20),

Title: The Innovative Journey of Inventor Yun He

Introduction: Yun He, a pioneering inventor hailing from Shanghai, China, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Yun He's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for early disease detection, and a sustainable energy solution for urban environments.

Career Highlights: With a career spanning over two decades, Yun He has established herself as a leading figure in the tech industry. Her innovative spirit and dedication to research have led to numerous successful patents and inventions that have shaped the future of various sectors.

Collaborations: Throughout her career, Yun He has collaborated with top research institutions, leading tech companies, and renowned universities to further her research and bring her inventions to life. Her collaborative efforts have resulted in groundbreaking technologies that have had a lasting impact on society.

Conclusion: Inventor Yun He's relentless pursuit of innovation and her passion for creating solutions to complex challenges have solidified her position as a trailblazer in the world of technology. Her remarkable inventions continue to inspire and drive progress in the ever-evolving tech landscape.